Detalhe da pesquisa
1.
Age- and Weight-Adapted Dose of Prasugrel Versus Standard Dose of Ticagrelor in Patients With Acute Coronary Syndromes : Results From a Randomized Trial.
Ann Intern Med
; 173(6): 436-444, 2020 09 15.
Artigo
Inglês
| MEDLINE | ID: mdl-32687741
2.
Comparison of vascular closure devices vs manual compression after femoral artery puncture: the ISAR-CLOSURE randomized clinical trial.
JAMA
; 312(19): 1981-7, 2014 Nov 19.
Artigo
Inglês
| MEDLINE | ID: mdl-25399273
3.
The effect of a Prasugrel- vs. a Ticagrelor-based strategy on total ischaemic and bleeding events in patients with acute coronary syndromes.
Eur Heart J Cardiovasc Pharmacother
; 9(3): 231-239, 2023 04 10.
Artigo
Inglês
| MEDLINE | ID: mdl-36434779
4.
High on-aspirin treatment platelet reactivity and restenosis after percutaneous coronary intervention: results of the Intracoronary Stenting and Antithrombotic Regimen-ASpirin and Platelet Inhibition (ISAR-ASPI) Registry.
Clin Res Cardiol
; 112(9): 1231-1239, 2023 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-36786829
5.
Ticagrelor or prasugrel in patients with acute coronary syndrome with off-hour versus on-hour presentation: a subgroup analysis of the ISAR-REACT 5 trial.
Clin Res Cardiol
; 112(4): 518-528, 2023 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-35789430
6.
One-Year Ischemic and Bleeding Events According to Renal Function in Patients With Non-ST-Segment Elevation Acute Coronary Syndromes Treated With Percutaneous Coronary Intervention and Third-Generation Antiplatelet Drugs.
Am J Cardiol
; 176: 15-23, 2022 08 01.
Artigo
Inglês
| MEDLINE | ID: mdl-35606172
7.
Meta-Analysis of Short vs. Prolonged Dual Antiplatelet Therapy after Drug-Eluting Stent Implantation and Role of Continuation with either Aspirin or a P2Y12 Inhibitor Thereafter.
J Atheroscler Thromb
; 29(7): 1001-1019, 2022 Jul 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34248087
8.
Efficacy and Safety of Ticagrelor Versus Prasugrel in Women and Men with Acute Coronary Syndrome: A Pre-specified, Sex-Specific Analysis of the ISAR-REACT 5 Trial.
J Atheroscler Thromb
; 29(5): 747-761, 2022 May 01.
Artigo
Inglês
| MEDLINE | ID: mdl-33867409
9.
Target and non-target vessel related events at 10 years post percutaneous coronary intervention.
Clin Res Cardiol
; 111(7): 787-794, 2022 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-35147767
10.
Periprocedural myocardial injury according to optical characteristics of neointima and treatment modality of in-stent restenosis.
Clin Res Cardiol
; 111(7): 827-837, 2022 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-35476138
11.
Pre-admission antiplatelet therapy and treatment effect of ticagrelor vs. prasugrel in patients with acute coronary syndromes-a subgroup analysis of the ISAR-REACT 5 trial.
Eur Heart J Cardiovasc Pharmacother
; 8(7): 687-694, 2022 Sep 29.
Artigo
Inglês
| MEDLINE | ID: mdl-35191982
12.
Body mass index and efficacy and safety of ticagrelor versus prasugrel in patients with acute coronary syndromes.
Rev Esp Cardiol (Engl Ed)
; 75(9): 747-755, 2022 Sep.
Artigo
Inglês, Espanhol
| MEDLINE | ID: mdl-34961732
13.
Comparison of Vascular Closure Devices vs Manual Compression After Femoral Artery Puncture in Patients on Oral Anticoagulation - Post Hoc Analysis of the ISAR-CLOSURE Trial.
J Invasive Cardiol
; 33(9): E709-E715, 2021 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-34170841
14.
Prognostic value of glomerular function estimated by Cockcroft-Gault creatinine clearance, MDRD-4, CKD-EPI and European Kidney Function Consortium equations in patients with acute coronary syndromes.
Clin Chim Acta
; 523: 106-113, 2021 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-34529983
15.
Assessment of Impact of Patient Recruitment Volume on Risk Profile, Outcomes, and Treatment Effect in a Randomized Trial of Ticagrelor Versus Prasugrel in Acute Coronary Syndromes.
J Am Heart Assoc
; 10(22): e021418, 2021 11 16.
Artigo
Inglês
| MEDLINE | ID: mdl-34779234
16.
Efficacy and safety of ticagrelor versus prasugrel in smokers and nonsmokers with acute coronary syndromes.
Int J Cardiol
; 338: 8-13, 2021 09 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34126130
17.
Ticagrelor or Prasugrel in Patients With Acute Coronary Syndrome Undergoing Complex Percutaneous Coronary Intervention.
Circ Cardiovasc Interv
; 14(7): e010565, 2021 07.
Artigo
Inglês
| MEDLINE | ID: mdl-34130477
18.
Ticagrelor or Prasugrel in Patients With Acute Coronary Syndrome in Relation to Estimated Glomerular Filtration Rate.
JACC Cardiovasc Interv
; 14(17): 1857-1866, 2021 09 13.
Artigo
Inglês
| MEDLINE | ID: mdl-34446390
19.
Ticagrelor or Prasugrel for Patients With Acute Coronary Syndrome Treated With Percutaneous Coronary Intervention: A Prespecified Subgroup Analysis of a Randomized Clinical Trial.
JAMA Cardiol
; 6(10): 1121-1129, 2021 10 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34190967
20.
Ticagrelor or Prasugrel in Patients With Acute Coronary Syndromes and Diabetes Mellitus.
JACC Cardiovasc Interv
; 13(19): 2238-2247, 2020 10 12.
Artigo
Inglês
| MEDLINE | ID: mdl-33032712